RaySearch Laboratories (STO:RAYB):
January 1 - March 31, 2011
· Net sales for the period totaled SEK 23.0 M (28.1)
· Profit after tax was SEK 1.6 M (8.2), corresponding to earnings per share of SEK 0.05 (0.24)
· Operating profit totaled SEK 2.1 M (11.2) · Cash flow was a negative SEK 3.3 M (negative: 1.8)
· RaySearch established a sales organization in the US
· Two new RayStation® orders received
· RaySearch licensed groundbreaking technology from Princess Margaret Hospital
SIGNIFICANT EVENTS AFTER THE CLOSE OF THE PERIOD
· Dutch clinic placed an order for RayStation® in April
"The beginning of 2011 was characterized by intensive work with strategic changes in RaySearch as we transition from complete dependence on partners to a structure with sales directly to clinics in parallel with the partner-based business model," says Johan Löf, President of RaySearch.
"We have already noted a growing interest in RayStation® following the breakthrough in the US and Europe, and I am convinced that our customer list will grow during 2011," concludes Johan Löf.